RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/38165
https://w3id.org/ripe/ripe-kg/retraction-notice/38165
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA10E0E50BEC9CF233 |
prov:used |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
prism:doi |
10.1208/s12249-022-02348-z |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
prism:publicationDate |
2022-07-11 |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
prism:publicationName |
AAPS PharmSciTech |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
dcterms:publisher |
ripekg:publisher/RIPEPC1F35FFD9E5268DESpringer |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
dcterms:title |
Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1208%2Fs12249-021-01934-x |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
rdf:type |
owl:Thing |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
owl:sameAs |
https://semopenalex.org/work/W4285077665 |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA10E0E50BEC9CF233 |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA10E0E50BEC9CF233 |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
ripe:concerns |
ripekg:author/RIPEAU94004D0173EFBA6BQiang Liu |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
ripe:concerns |
ripekg:work/10.1208%2Fs12249-021-01934-x |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
ripe:rationale |
Author Unresponsive;Concerns/Issues About Authorship/Affiliation;Original Data and/or Images not Provided and/or not Available;Unreliable Data |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
ripe:retractionWatchRecordId |
38165 |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA10E0E50BEC9CF233-human-1-3 |
ripekg:retraction-notice/38165Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA10E0E50BEC9CF233-inspectai-1-3 |